News 20 Jun 14

Ratko Mladic Trial Again Interrupted by Illness

The war crimes trial of the former Bosnian Serb military leader, which has been suspended several times because of Mladic’s health, was interrupted again when he was hospitalised.

Justice Report

Mladic’s trial did not resume this week after he was taken to Bronovo hospital in The Hague on Monday suffering from stomach flu, his defence lawyer, Branko Lukic, told the judges.

After spending a day being treated, Mladic was returned to the hospital in the Hague Tribunal’s detention unit in Scheveningen.

Presiding judge Alphons Orie said that Mladic had not given up his right to attend the trial and so it could not continue in his absence.

Mladic has already had two strokes during the course of the trial, which began in 2012.

He is charged with genocide in Srebrenica, the persecution of Muslims and Croats throughout Bosnia and Herzegovina, which reached the scale of genocide in seven municipalities, terrorising the population of Sarajevo and taking UN peacekeepers hostage.

It’s not yet clear whether the trial will resume next week.

Talk about it!

blog comments powered by Disqus

Latest Headlines

News 18 Oct 17

Ratko Mladic Trial Verdict Set for November 22

Feature 07 Aug 17

Ailing Defendants Cause Headaches for Hague Tribunal

News 14 Jul 17

Bosnian Serbs Spend €10,000 on Mladic, Karadzic

News 06 Jul 17

Bosnian Serbs to Rally for Ratko Mladic

News 23 May 17

Mladic Appeals ICTY Denial of Temporary Release


Srebrenica: Genocide Reconstructed

In July 1995 Srebrenica was shelled and occupied by the Army of Republic of Srpska,VRS, despite being declared a protected area by the United Nations. More than 7,000 people were killed, the victims of genocide.

War in Bosnia

Key dates and events in the Bosnia war.

Ratko Mladic: The Force Behind the Srebrenica Killings

The Bosnian Serb commander’s role in the genocide committed in Srebrenica is described in detail in many indictments and verdicts pronounced before local and international judicial institutions.

Subscribe to Our Newsletter